Catalyst Wealth Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Catalyst Wealth Management's ELV Position: Q1 2023 in Review
Catalyst Wealth Management sold out of Elevance Health (ELV) in Q1 2023, closing a stake of 422 shares — an estimated $216K sold.
Catalyst Wealth Management first reported a position in ELV in Q4 2022 and held it in 1 quarter. The position peaked at $216K in Q4 2022. 1,517 funds tracked by Wall St. Rank hold ELV as of Q1 2023.
- Catalyst Wealth Management reported no remaining Elevance Health position as of Q1 2023 after selling out during the quarter.
- Catalyst Wealth Management sold 422 Elevance Health shares in Q1 2023, an estimated $216K.
- Catalyst Wealth Management first reported a position in Elevance Health in Q4 2022 and held it in 1 quarter.
- Catalyst Wealth Management's Elevance Health position peaked at $216K in Q4 2022.
- 1,517 funds tracked by Wall St. Rank held Elevance Health as of Q1 2023.
Based on Catalyst Wealth Management's 13F filing for Q1 2023, filed 11 Apr 2023.